Pharma & Bio
Technology
Peptron, Inc.: Two Years Waiting for Lilly’s Response… Anticipation for Follow-up DDS Contract and Clinical Trial Announcements [Bio Monthly Roundup]
In October, the focus of the domestic pharmaceutical and biotech market is expected to shift to follow-up contracts by drug delivery system (DDS) companies and clinical results to be presented at glob…
Technology
Two Doses of ‘APB-R3’ Provide 12-Week Effect… AprilBio Co.,Ltd. ‘SAFA’ Offers a Glimmer of Hope
AprilBio Co.,Ltd.(397030)The atopic dermatitis treatment “EVO301” (APB-R3), which Safa (SAFA) licensed to U.S.-based Evomune, has reaffirmed its efficacy in a Phase 2a clinical trial and is moving on …
Lifestyle
SG Bio Shakes Off Its ‘Seegene Captive’ Status… Achieves ‘7:3’ Golden Ratio in Revenue Structure
SG BioScience (formerly SG CO., LTD.; hereinafter “SG Bio”), a company specializing in in vitro diagnostics, is significantly reducing its “reliance on Seegene Inc.,” which has long been identified as…
Technology
Returned After 2 Years and 8 Months of Development Halt… The Importance of Rights Reclamation Highlighted by HanmiPharm’s ‘Belbarafenib’
HanmiPharm(128940)The company is set to regain the overseas rights to “Belvarapenib,” an anti-cancer candidate compound it licensed to U.S.-based Genentech 10 years ago. Although Genentech officially …
Technology
Beyond Technology Exports to Licensing and Sales… HLB INC.’s ‘Ripictu’ Blazes a New Trail for K-Bio
HLB INC.(028300)has cleared the U.S. Food and Drug Administration (FDA) hurdle for the first time. This comes after the company had suffered three consecutive setbacks with its new liver cancer drug, …
Technology
AriBio Holdings Hits Lower Limit After Scrapping Merger With AriBio [K-bio bulse]
Korean pharmaceutical, biotech, and healthcare stocks showed sharply mixed movements on September 29 as company-specific news drove trading. AriBio Holdings plunged to its daily lower limit in after-h…
Technology
Holding Company Plummets After AriBio Withdraws Merger… HLB PHARMACEUTICAL Jumps 63% in Two Days [Bio Spotlight]
On the 29th, #AriBioHoldings announced it was withdrawing the absorption merger with AriBio, a plan it had been pursuing for over two years, causing its stock to plummet to the daily lower limit in af…
Technology
Kolmar Korea Acquires Blue M-Tech… From ‘AI and Data’-Based Distribution to Synergies with HK Innoen
#Kolmar Korea Holdings is drawing attention as it moves to acquire #Blue M Tech, a pharmaceutical distribution platform company. This move is interpreted as an effort by the Kolmar Group—which special…
Technology
Taking on Japan’s Olympus… ‘Korean AI-Powered Endoscope’ Picked by Seoul National University Professor [Expert Insight]
Endoscopic examinations place a significant physical strain on medical staff. They must operate the controls—which weigh over 600g—using their fingers and wrists, and in the case of therapeutic endosc…
Lifestyle
Investor Sentiment Rebounds; HLB, VUNO, and BNC Korea Drive Market Turning Point [K-Bio Pulse]
The driving force behind the KOSDAQ rebound on the 28th was the pharmaceutical, biotechnology, and medical device (bio) sector, led by the HLB Group. Overcoming macroeconomic uncertainties and a prolo…